ester (GE Healthcare, 0.75 μmol) with 1.5-fold excess(1.13
μmol) of amine-terminated benzylguanine (NH2-BG; New England BioLabs)
in the presence of 1.13 μmol triethylamine in dimethylformamide. The
reaction (103 μL) was incubated overnight on a rotating platform at
30°C. The Cy3B-BG product was purified by reverse phase HPLC on an
Agilent ZORBAX Eclipse Plus 95Å column and dried by speed-vac
evaporation (46% yield).
SNAP-tagged PUF proteins were labeled by incubating 5–10
μM of purified protein with 20 μM of Cy3B-BG in Buffer C. The
tube was covered with aluminum foil and rotated at 4°C for
12–14 h. Unincorporated dye was removed with Zeba Spin Desalting
Columns (Thermo Fisher Scientific) equilibrated with Buffer C; the protein
was concentrated using Amicon Ultra 10KDa filters and diluted two-fold with
Buffer C containing 80% glycerol for final storage at −20°C.
The labeling efficiencies (based on total protein concentration and Cy3B
absorbance at 559 nm; Cy3B extinction coefficient: 130,000
M−1cm−1) were 60% (PUM2-SNAP), 53%
(SNAP-PUM1) and 36% (mutant SNAP-PUM1).